Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections
NCT00417573
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
IgG Deficiency
Infections
Interventions
DRUG:
IV Gamunex 10%
Sponsor
The Center for Rheumatic Disease, Allergy, & Immunology
Collaborators
[object Object]